The efficacy of naftopidil in treatment of female urethral syndrome
- VernacularTitle:萘哌地尔治疗女性尿道综合征的临床体会
- Author:
Houbao HUANG
;
Shuchuan JIANG
;
Changbin DONG
;
Lixin QIAN
- Publication Type:Journal Article
- Keywords:
Naftopidil;
Female urethral syndrome;
Efficacy;
Safety
- From:
Journal of Medical Postgraduates
2003;0(09):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To evaluate the efficacy and safety of Naftopidil on patients with female urethral syndrome (FUS). Methods: Self-controlled clinical trial was performed in patients with FUS. Thirty-eight patients were treated with naftopidil tablet 25mg/po/qn for 4 weeks after one-week washout period. The effects were evaluated mainly by female urethral syndrome score (FUSS) and quality of life (QOL). Results: FUSS began to decrease after 2 (week's) administration and decreased significantly after 4 weeks' treatment. It had statistically significant difference of FUSS and QOL after treatment compared with control (P
